# Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy

> **NCT03657849** · NA · COMPLETED · sponsor: **HealthPartners Institute** · enrollment: 60 (actual)

## Conditions studied

- Enlarged Lymph Nodes (Excluding Infective)

## Interventions

- **DEVICE:** EBUS TBNA

## Key facts

- **NCT ID:** NCT03657849
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-18
- **Primary completion:** 2019-01-25
- **Final completion:** 2019-08-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657849, "Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03657849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*